StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cellectar Biosciences's market cap was $9.99M on Nov 11, 2026, against $11.46M a year earlier. Over the last 5 years it ranged from $6.14M to $102.49M, with a median of $15.20M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.99M+6.0%
2025Dec 31, 2025$9.42M-22.4%
2024Dec 31, 2024$12.13M-55.9%
2023Dec 29, 2023$27.48M+163.0%
2022Dec 30, 2022$10.45M-74.2%
2021Dec 31, 2021$40.58M-27.3%
2020Dec 31, 2020$55.78M+164.1%
2019Dec 31, 2019$21.12M+219.1%
2018Dec 31, 2018$6.62M-64.2%
2017Dec 29, 2017$18.46M+182.0%
2016Dec 30, 2016$6.55M+17.1%
2015Dec 31, 2015$5.59M-76.1%
2014Dec 31, 2014$23.36M+9.6%
2013Dec 31, 2013$21.31M-33.3%
2012Dec 31, 2012$31.97M+169.1%
2011Dec 30, 2011$11.88M–

More Cellectar Biosciences figures

See a number that looks wrong?